Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival
Open accessThe DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
Colony-stimulating factor 1 (CSF1) and interleukin-34 (IL-34) are functional ligands of the CSF1 receptor (CSF1R) and thus are key regulators of the monocyte/macrophage lineage. We discovered that systemic administration of human recombinant CSF1 ameliorates memory deficits in a transgenic mouse model of Alzheimer’s disease. CSF1 and IL-34 strongly reduced excitotoxin-induced neuronal cell loss and gliosis in wild-type mice when administered systemically before or up to 6 h after injury. These effects were accompanied by maintenance of cAMP responsive element–binding protein (CREB) signaling in neurons rather than in microglia. Using lineage-tracing experiments, we discovered that a small number of neurons in the hippocampus and cortex express CSF1R under physiological conditions and that kainic acid–induced excitotoxic injury results in a profound increase in neuronal receptor expression. Selective deletion of CSF1R in forebrain neurons in mice exacerbated excitotoxin-induced death and neurodegeneration. We conclude that CSF1 and IL-34 provide powerful neuroprotective and survival signals in brain injury and neurodegeneration involving CSF1R expression on neurons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







![Figure 8. CSF1 maintains CREB phosphorylation. (A–D) CSF1 maintains CREB phosphorylation after KA lesion. Wild-type FVB/N mice (n = 4 per group, 2 mo of age) were lesioned with 20 mg/kg KA (subcutaneous injection) or injected with PBS as control. For treatment, CSF1 or PBS was applied 24 h before KA. Mice were sacrificed 6 h after KA injection. One hemibrain was fixed for immunohistochemistry with an antibody against p-CREB (A, left and middle), and p-CREB immunoreactivity was quantified as percentage of area occupied (B). The opposite hippocampi were isolated and subjected to Western blot analysis for p-CREB (C), which was quantified as optical intensity (D). Results are from one out of two independent experiments. (E and F) CSF1 restores CREB signaling in hAPP mice. hAPP mice and their nTG littermates (Fig. 1 A) were treated with 800 µg/kg CSF1 or PBS three times a week. 10 wk later, the mice were sacrificed after water maze behavior test, and one hemibrain was analyzed by immunohistochemistry for p-CREB immunoreactivity. The experiment was performed once. Error bars indicate SEM. Bars: (A, left) 200 µm; (A [middle and right] and E) 50 µm. *, P < 0.05; **, P < 0.01 compared by ANOVA and Bonferroni post-hoc test (B and F) or Student’s t test (D).](https://figures.cochat.ai/paper-figures/c0d130c8f62e426fa46ee8a529a15acf/colony-stimulating-factor-1-receptor-csf1r-signaling-in-injured-neurons-figure-8.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“studies in mouse models suggest that CSF1R ligands, such as IL-34 and CSF1, may provide neuroprotective and survival signals in neurodegeneration by activating CSF1R on selected neuron populations rather than microglia (194).”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [194]
Experimental — accuracy not yet measuredIn the citing paper
“CSF1R signaling in a selected neuron population, rather than in microglia, provides neuroprotective and survival signals in the neurodegeneration setting (146).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [146]
In the citing paper
“the MD5828- specific metagene for factor 5, which was microglia-specific, had high loadings of TMSB4X and CSF1R, both of which play important roles in the acute response to TBI (Luo et al., 2013; Xiong et al., 2012).”
From Single-Cell Multi-omic Integration Compares and Contrasts Features of Brain Cell Identity (2019) · cites this paper as Luo et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Penkowa, M., Poulsen, C. B., Carrasco, J., & Hidalgo, J. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7968 · Cited by 20
RetractedFate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
The molecular biology of memory storage: a dialogue between genes and synapses
Kandel, E. R. (2001) · Science · doi:10.1126/science.1067020 · Cited by 3,917
A global double-fluorescent Cre reporter mouse
Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L., & Luo, L. (2007) · genesis · doi:10.1002/dvg.20335 · Cited by 3,491
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
‘Green mice’ as a source of ubiquitous green cells
Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T., & Nishimune, Y. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00313-x · Cited by 2,581 · cited 3×
“The following transgenic mouse lines were used: hAPP mice (line 41) expressing mutated (London V717I and Swedish K670M/N671L) human APP751 under the control of the mouse Thy1 promoter (Rockenstein et al., 2001), GFAP-luc mice (Caliper Life Science; Zhu et al., 2004), CSF1-null Csf1op/Csf1op mice (The Jackson Laborator…”
BackgroundMethodFunction and regulation of CREB family transcription factors in the nervous system
Lonze, B. E., & Ginty, D. D. (2002) · Neuron · doi:10.1016/s0896-6273(02)00828-0 · Cited by 2,127
Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789
The ageing systemic milieu negatively regulates neurogenesis and cognitive function
Villeda, S. A., Luo, J., Mosher, K. I., Zou, B., Britschgi, M., Bieri, G., Stan, T. M., Fainberg, N., Ding, Z., Eggel, A., et al. (2011) · Nature · doi:10.1038/nature10357 · Cited by 1,763
Self-citation
Cited by
Items 101–200 of 281
Johnson, N. R., Yuan, P., Castillo, E., Lopez, T. P., Yue, W., Bond, A., Rivera, B. M., Sullivan, M. C., Hirouchi, M., Giles, K., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35753-w · Cited by 46
Ferro, A., Sheeler, C., Rosa, J.-G., & Cvetanovic, M. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.01.016 · Cited by 46
Macrophages Generate Pericytes in the Developing Brain
Prazeres, P. H. D. M., de Almeida, V. M., Lousado, L., Andreotti, J. P., Paiva, A. E., Santos, G. S. P., de Azevedo, P. O., Souto, L., Almeida, G. G., Filev, R., et al. (2017) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0549-2 · Cited by 46
Ge, Y., Huang, M., & Yao, Y.-M. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.35070 · Cited by 46
Bollinger, J. L., Horchar, M. J., & Wohleb, E. S. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0720-1 · Cited by 45
Guenoun, D., Blaise, N., Sellam, A., Roupret‐Serzec, J., Jacquens, A., Steenwinckel, J. V., Gressèns, P., & Bokobza, C. (2024) · Glia · doi:10.1002/glia.24664 · Cited by 45
Wies Mancini, V. S. B., Pasquini, J. M., Correale, J. D., & Pasquini, L. A. (2019) · Glia · doi:10.1002/glia.23540 · Cited by 44
Xiao, H., Li, S., Doycheva, D. M., Huang, L., Lenahan, C., Liu, R., Huang, J., Gao, L., Tang, J., Zuo, G., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6801587 · Cited by 43
Crisafulli, S. G., Brajkovic, S., Mis, M. S. C., Parente, V., & Corti, S. P. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0532-4 · Cited by 43
Clinicopathologic characterization and abnormal autophagy of CSF1R-related leukoencephalopathy
Tian, W., Zhan, F., Liu, Q. F., Luan, X., Zhang, C., Shang, L., Zhang, B., Pan, S., Miao, F., Hu, J., et al. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0171-y · Cited by 42
Cheng, B., Li, X., Dai, K., Duan, S., Rong, Z., Chen, Y., Lü, L., Liu, Z., Huang, X., Xu, H., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.633796 · Cited by 40
Excitatory Neuron-Derived Interleukin-34 Controls Cortical Developmental Microglia Function
Devlin, B. A., Nguyen, D. M., Ribeiro, D., Grullon, G., Clark, M. J., Finn, A., Ceasrine, A. M., Oxendine, S. R., Deja, M., Shah, A., et al. (2024) · Immunity · doi:10.1016/j.immuni.2025.06.002 · Cited by 40
Basic Concept of Microglia Biology and Neuroinflammation in Relation to Psychiatry
Mattei, D., & Notter, T. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2018_83 · Cited by 39
Beyond Immunity: Underappreciated Functions of Intestinal Macrophages
Chiaranunt, P., Tai, S. L., Ngai, L., & Mortha, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.749708 · Cited by 40
Differential regulation of microglial states by colony stimulating factors
Stanley, E. R., Biundo, F., Gökhan, Ş., & Chiţu, V. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1275935 · Cited by 38
Groh, J., Klein, D., Berve, K., West, B. L., & Martini, R. (2018) · Glia · doi:10.1002/glia.23539 · Cited by 38
Li, F., & Liu, L. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116621 · Cited by 38
Interleukin-34 Ameliorates Survival and Bacterial Clearance in Polymicrobial Sepsis*
Lin, X., Luo, H., Yan, X., Song, Z., Gao, X., Xia, Y., Zhang, L., Yin, Y., & Cao, J. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003017 · Cited by 38
Proteolytic cleavage of Beclin 1 exacerbates neurodegeneration
Bieri, G., Lucin, K. M., O’Brien, C. E., Zhang, H., Villeda, S., & Wyss‐Coray, T. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0302-4 · Cited by 36
Self-citationCSF-1 in Inflammatory and Arthritic Pain Development
Saleh, R., Lee, M.-C., Khiew, S. H. W., Louis, C., Fleetwood, A. J., Achuthan, A. A., Förster, I., Cook, A. D., & Hamilton, J. A. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800665 · Cited by 36
BLZ945 derivatives for PET imaging of colony stimulating factor-1 receptors in the brain
van der Wildt, B., Miao, Z., Reyes, S. T., Park, J. H., Klockow, J., Zhao, N., Romero, A., Guo, S. G., Shen, B., Windhorst, A. D., et al. (2021) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2021.06.005 · Cited by 36
Rh‐CSF1 attenuates neuroinflammation via the CSF1R/PLCG2/PKCε pathway in a rat model of neonatal HIE
Hu, X., Li, S., Doycheva, D. M., Huang, L., Lenahan, C., Liu, R., Huang, J., Xie, S., Tang, J., Zuo, G., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01862-w · Cited by 35
Brain rhythms control microglial response and cytokine expression via NF-κB signaling
Prichard, A., Garza, K. M., Shridhar, A., He, C. L., Bitarafan, S., Pybus, A. F., Wang, Y., Snyder, E., Goodson, M. C., Franklin, T., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf5672 · Cited by 34
Khoshnan, A., Sabbaugh, A., Calamini, B., Marinero, S., Dunn, D., Yoo, J. H., Ko, J., Lo, D. C., & Patterson, P. H. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx315 · Cited by 33
Tang, Y., Xiao, Z., Pan, L., Zhuang, D., Cho, K., Robert, K., Chen, X., Shu, L., Tang, G., Wu, J., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585918 · Cited by 33
Sex- and region-biased depletion of microglia/macrophages attenuates CLN1 disease in mice
Berve, K., West, B. L., Martini, R., & Groh, J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01996-x · Cited by 32
Cancer neuroscience: signaling pathways and new therapeutic strategies for cancer
Zhang, S., Yuan, L., Lin, P., Yang, G., Zhou, X., Jinfu, X., Wu, M., & Huang, Y. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02364-y · Cited by 32
Sánchez-Niño, M. D., Sanz, A. B., & Ortíz, A. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw026 · Cited by 31
Gerngross, L., Lehmicke, G., Belkadi, A., & Fischer, T. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0272-1 · Cited by 30
de Rojas, I., Moreno-Grau, S., Tesi, N., Grenier-Boley, B., Andrade, V., Jansen, I., Pedersen, N. L., Stringa, N., Zettergren, A., Hernández, I., et al. (2019) · doi:10.1101/19012021 · Cited by 28
Karrer, M., Lopez, M., Meier, D. T., Mikhail, C., Ogunshola, O. O., Müller, A. F., Strauss, L., Tafti, M., & Fontana, A. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.11.008 · Cited by 27
Tarale, P., & Alam, M. M. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-00958-4 · Cited by 26
1α,25-Dihydroxyvitamin D3 up-regulates IL-34 expression in SH-SY5Y neural cells
Zhang, D., Li, M., Dong, Y., Zhang, X., Liu, X., Chen, Z., Zhu, Y., Wang, H., Liu, X., Zhu, J., et al. (2017) · Innate Immunity · doi:10.1177/1753425917725391 · Cited by 26
Alzheimer’s Disease Genetics: A Dampened Microglial Response?
Chatila, Z. K., & Bradshaw, E. M. (2021) · The Neuroscientist · doi:10.1177/10738584211024531 · Cited by 25
Khan, A. S., Ju, F., Xie, W., Hafeez, M. T., Cheng, X., Yang, Z., Zhu, L., Li, T., & Zhang, S. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.02.019 · Cited by 25
Self-citationEvolving Models and Tools for Microglial Studies in the Central Nervous System
Zhang, Y., & Cui, D. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00706-8 · Cited by 25
Chandrasekaran, S., & Bonchev, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0144052 · Cited by 25
Zwicker, S., Bureik, D., Bosma, M., Martinez, G., Almer, S. H., & Boström, E. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167324 · Cited by 25
Catale, C., Bisicchia, E., Carola, V., & Viscomi, M. T. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.02.032 · Cited by 24
Dorion, M., Casas, D., Shlaifer, I., Yaqubi, M., Fleming, P., Karpilovsky, N. C., Chen, C. X. ‐., Nicouleau, M., Piscopo, V. E. C., MacDougall, E. J., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00723-x · Cited by 23
Treatment With the CSF1R Antagonist GW2580, Sensitizes Microglia to Reactive Oxygen Species
Soto‐Díaz, K., Vailati-Riboni, M., Louie, A. Y., McKim, D. B., Gaskins, H. R., Johnson, R. W., & Steelman, A. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.734349 · Cited by 22
Microglial responses to CSF1 overexpression do not promote the expansion of other glial lineages
De, I., Maklakova, V. I., Litscher, S. J., Boyd, M. M., Klemm, L. C., Wang, Z., Kendziorski, C. M., & Collier, L. S. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02212-0 · Cited by 22
Genetic associations with age at dementia onset in the PSEN1 E280A Colombian kindred
Cochran, J. N., Acosta‐Uribe, J., Esposito, B. T., Madrigal, L., Aguillón, D., Giraldo, M. M., Taylor, J. W., Bradley, J., Fulton‐Howard, B., Andrews, S. J., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13021 · Cited by 21
Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer’s Disease
Weissmann, R., Hüttenrauch, M., Kacprowski, T., Bouter, Y., Pradier, L., Bayer, T. A., Kuss, A. W., & Wirths, O. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150745 · Cited by 21
Li, K., Ran, B., Wang, Y., Liu, L., & Li, W. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.999061 · Cited by 18
Hume, D. A., Teakle, N., Keshvari, S., & Irvine, K. M. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad052 · Cited by 18
Piccioni, G., Maisto, N., d’Ettorre, A., Strimpakos, G., Nisticò, R., Triaca, V., & Mango, D. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03019-2 · Cited by 17
Altered Gene Expression in Prefrontal Cortex of a Fabry Disease Mouse Model
Kummer, K. K., Kalpachidou, T., Mitrić, M. M., Langeslag, M., & Kress, M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00201 · Cited by 17
Ramirez, J., Bitterman, P., Basu, S., & Barua, A. (2022) · Journal of Immunology Research · doi:10.1155/2022/2870389 · Cited by 17
Wiens, K. R., Wasti, N., Ulloa, O. O., & Klegeris, A. (2024) · Molecules · doi:10.3390/molecules29235525 · Cited by 16
Li, L., Yerra, L. P., Chang, B., Mathur, V., Nguyen, A., & Luo, J. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.01.022 · Cited by 16
Self-citationGlycoproteomic Study Reveals Altered Plasma Proteins Associated with HIV Elite Suppressors
Yang, W., Laeyendecker, O. B., Wendel, S. K., Zhang, B., Sun, S., Zhou, J.-Y., Ao, M., Moore, R. D., Jackson, J. B., & Zhang, H. (2014) · Theranostics · doi:10.7150/thno.9510 · Cited by 16
Self-citationInvestigation Into the Role of ERK in Tyrosine Kinase Inhibitor-Induced Neuropathy
Belair, D. G., Sudak, K., Connelly, K., Collins, N. D., Kopytek, S., & Kolaja, K. L. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab033 · Cited by 15
Yan, Y., Truitt, B., Tao, J., Boyles, S. M., Antoine, D., Hulme, W. F., & Roy, S. (2023) · iScience · doi:10.1016/j.isci.2023.108166 · Cited by 15
Mizobuchi, H., Yamamoto, K., Yamashita, M., Nakata, Y., Inagawa, H., Kohchi, C., & Soma, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.650176 · Cited by 14
Altered structural and functional connectivity in CSF1R-related leukoencephalopathy
Zhan, F., Zhu, Z., Liu, Q., Zhou, H., Luan, X., Huang, X., Liu, X., Tian, W., Wang, S., Song, X., et al. (2020) · Brain Imaging and Behavior · doi:10.1007/s11682-020-00360-0 · Cited by 14
Recent Advances in Basic Research for CSF1R-Microglial Encephalopathy
Wang, Y., Wang, F.-Z., Li, R., Jiang, J., Liu, X., & Xu, J. L. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.792840 · Cited by 14
Epithelioid glioblastoma with microglia features: potential for novel therapy
Nakagomi, N., Sakamoto, D., Hirose, T., Takagi, T., Murase, M., Nakagomi, T., Yoshimura, S., & Hirota, S. (2020) · Brain Pathology · doi:10.1111/bpa.12887 · Cited by 14
Du, X., Gao, F., Chen, S., Botchway, B. O. A., Amin, N., Hu, Z., & Fang, M. (2020) · Mediators of Inflammation · doi:10.1155/2020/8796103 · Cited by 14
CSF1R antagonism results in increased supraspinal infiltration in EAE
Wang, M., Caryotakis, S. E., Smith, G., Nguyen, A. V., Pleasure, D., & Soulika, A. M. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03063-1 · Cited by 13
Colony stimulating factor 1: friend or foe of neurons?
Bo, X., & Bo, L. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.322451 · Cited by 13
Abdel-Dayem, M. A., Shaker, M. E., & Gameil, N. M. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577062 · Cited by 13
Clare, A. J., Day, R. C., Empson, R. M., & Hughes, S. M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00410 · Cited by 12
Hutchinson, J. M., & Isaacson, L. G. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146328 · Cited by 12
Proteomic biomarkers of Kleine–Levin syndrome
Hedou, J. J., Cederberg, K. L. J., Ambati, A., Lin, L., Farber, N. M., Dauvilliers, Y. A., Quadri, M., Bourgin, P., Plazzi, G., Andlauer, O., et al. (2022) · SLEEP · doi:10.1093/sleep/zsac097 · Cited by 12
Kawabe, M., Ohyama, H., Kato‐Kogoe, N., Yamada, N., Yamanegi, K., Nishiura, H., Hirano, H., Kishimoto, H., & Nakasho, K. (2014) · Medical Molecular Morphology · doi:10.1007/s00795-014-0094-8 · Cited by 12
Mizobuchi, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1110583 · Cited by 11
Molecular landscape of the overlap between Alzheimer’s disease and somatic insulin-related diseases
Ruisch, I. H., Widomska, J., Witte, W. D., Mota, N. R., Fanelli, G., van Gils, V., Jansen, W. J., Vos, S. J. B., Fóthi, Á., Barta, C., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01609-2 · Cited by 11
Saitoh, B., Yamasaki, R., Hiwatashi, A., Matsushita, T., Hayashi, S., Mitsunaga, Y., Maeda, Y., Isobe, N., Yoshida, K., Ikeda, S.-I., et al. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.03.008 · Cited by 11
Altomonte, S., & Pike, V. W. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00213 · Cited by 11
Meraz‐Ríos, M. A., Rochín-Hernández, L. J., Ramírez-Reyes, L., Figueroa‐Corona, M. D. P., Sánchez-González, V., Orozco-Barajas, M., & Jiménez-Acosta, M. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612606 · Cited by 11
Wohleb, E. S., Terwilliger, R. Z., Duman, C. H., & Duman, R. S. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.02.1119 · Cited by 10
An update on novel and emerging therapeutic targets in Parkinson’s disease
Sawant, R., & Godad, A. P. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01390-z · Cited by 10
Chen, L., Yu, Y., Liu, E., Duan, L., Zhu, D., Chen, J., Dai, J. M., & Duan, Y. (2018) · Parasitology Research · doi:10.1007/s00436-018-6165-3 · Cited by 10
Salarian, M., Liu, S., Tsai, H., Leslie, S. N., Hayes, T. R., Lo, S., Szardenings, A. K., Zhang, W., Chen, G., Sandiego, C. M., et al. (2025) · Molecular Imaging and Biology · doi:10.1007/s11307-025-01991-9 · Cited by 10
Lapierre, J., Karuppan, M. K. M., Pokharel, M. D., Rodriguez, M., & El‐Hage, N. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10017-4 · Cited by 9
Single-nucleus transcriptomic mapping uncovers targets for traumatic brain injury
Yang, Q., Zhang, L., Li, M., Xu, Y., Chen, X., Yuan, R., Ou, X., He, M., Liao, M., Zhang, L., et al. (2023) · Genome Research · doi:10.1101/gr.277881.123 · Cited by 9
Li, C., Chen, Y., Luo, S., Yang, Y., Liu, X., Li, S., Ge, W., & Han, C. (2024) · Aging and Disease · doi:10.14336/ad.2024.10530 · Cited by 9
Biological functions and clinical implications of interleukin-34 in inflammatory diseases
Ge, Y., Huang, M., Zhu, X., & Yao, Y.-M. (2019) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.02.003 · Cited by 8
Paparone, S., Severini, C., Ciotti, M. T., D’Agata, V., Calissano, P., & Cavallaro, S. (2016) · Cell Death Discovery · doi:10.1038/cddiscovery.2016.50 · Cited by 8
Decreased Levels of Serum IL‐34 Associated with Cognitive Impairment in Vascular Dementia
Wang, Y., Lü, W., Ning, W., Chen, Y., & Li, L. (2021) · BioMed Research International · doi:10.1155/2021/6793860 · Cited by 8
Naderi, N., Yousefi, H., Mollazadeh, S., Mikaeili, A. S., Keshavarz-Norouzpour, M., Jazebi, M., Asl, S. S. M. N., Namvar, A., Saraji, A. A., Agi, E., et al. (2019) · Pediatric Hematology and Oncology · doi:10.1080/08880018.2019.1585503 · Cited by 8
Xia, Y., Chen, C., Chen, J., Hu, C., Yang, W., Wang, L., Liu, L., Gao, L.-P., Wu, Y.-Z., Chen, D.-D., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02989-y · Cited by 7
Chiţu, V., Caescu, C. I., Stanley, E. R., Lennartsson, J., Rönnstrand, L., & Heldin, C. (2015) · Springer eBooks · doi:10.1007/978-3-319-11888-8_10 · Cited by 7
Wu, K., Shao, S., Dong, Y.-T., Liu, Y.-Y., Chen, X.-H., Cheng, P., Qin, X., Peng, X., & Zhang, Y.-M. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110373 · Cited by 7
Taylor, I., Patkar, O. L., Liu, Y., Jacquelin, S., Green, E. K., Ranpura, G. N., Carter‐Cusack, D., Rosendahl, N., Ewing, A. D., Kurniawan, N. D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.16.633478 · Cited by 6
Rumberger, A. S., Vassel, L. A., Hess, C. C., Barnett, A. S., Johnson, B. J., Hassan, S., Godbout, J. P., & Niraula, A. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70186 · Cited by 6
Emerging roles of IL-34 in neurodegenerative and neurological infectious disease
Chhetri, G. (2021) · International Journal of Neuroscience · doi:10.1080/00207454.2021.1963962 · Cited by 7
Korczeniewska, O. A., Husain, S., Hoque, M., Soteropoulos, P., Khan, J., Eliav, E., & Benoliel, R. (2023) · Journal of Pain · doi:10.1016/j.jpain.2023.07.024 · Cited by 6
Qian, D., Lu, S., Hu, Y., Leng, B., & Qin, X. (2025) · Molecular Brain · doi:10.1186/s13041-025-01259-x · Cited by 5
The latest perspectives of small molecules FMS kinase inhibitors
Alkubaisi, B. O., Aljobowry, R., Ali, S. M., Sultan, S., Zaraei, S., Ravi, A., Al‐Tel, T. H., & El-Gamal, M. I. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115796 · Cited by 5
Macrophage/microglia-dependent mechanisms drive retinal pigment epithelium regeneration in zebrafish
Leach, L. L., Gonzalez, R. G., Jayawardena, S. U., & Gross, J. M. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116325 · Cited by 5
Soytürk, H., & Yılmaz, M. (2020) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.66.11.1583 · Cited by 5
Zhang, W., Song, X., & Zhifen, Z. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6857 · Cited by 5
Eligator, T., Chatterjee, J., Yamada, S., Kirchner, A., Nair, H. B. B., Fangusaro, J., & Gutmann, D. H. (2025) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaf215 · Cited by 5
Ambeskovic, M., Truica, S., McCreary, J. K., Faraji, J., Fang, X., Olson, D. M., & Metz, G. A. S. (2025) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2025.100104 · Cited by 4
Ueno, H., Hattori, T., Chi, H.-H., Miyabe, Y., & Murayama, M. A. (2024) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.24-0063 · Cited by 4
Bollinger, J. L., Horchar, M. J., & Wohleb, E. S. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001759 · Cited by 3
Elucidation of the role of microglia‐macrophage‐based neuroinflammation in neurological diseases
Yamasaki, R. (2024) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12829 · Cited by 3
Mécanismes de chronicisation de la douleur post-opératoire
Tassou, A. (2020) · theses.fr (ABES) · doi:10.70675/ca784204zd9abz41a2zbb2ezf5abac616807 · Cited by 3
Metadata
- Authors
- Luo, J., Elwood, F., Britschgi, M., Villeda, S., Zhang, H., Ding, Z., Zhu, L., Alabsi, H., Getachew, R., Narasimhan, R., Wabl, R., Fainberg, N., James, M. L., Wong, G., Relton, J., Gambhir, S. S., Pollard, J. W., & Wyss-Coray, T.
- Affiliations
- Stanford Medicine (US)
- Albert Einstein College of Medicine (US)
- Biogen (United States) (US)
- Department of Neurology and Neurological Sciences 1 and 2
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2013-01-07
- Volume
- 210
- Issue
- 1
- Pages
- 157-172
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3549715
- OpenAlex
- W2171223421
- Cited by
- 262
- References
- 80
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 21 · 2023: 15 · 2022: 16 · 2021: 43 · 2020: 24 · 2019: 29 · 2018: 22 · 2017: 20 · 2016: 16 · 2015: 12 · 2014: 16 · 2013: 4
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc-sa)
- Funders
- Biogen
- National Institutes of Health
- National Institute on Aging (R21AG023708, AG20603, AG23708, R01AG020603)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- CSF-1 receptor, CSF-1, IL-34, neuroprotection, excitotoxicity, neurodegeneration, CREB signaling, hippocampus, cortex, gliosis, monocyte/macrophage lineage
- MeSH terms
- Animals, Base Sequence, Cell Survival, Cognition, Disease Models, Animal, Humans, Interleukins, Kainic Acid, Mice, Inbred C57BL, Mice, Transgenic, Molecular Sequence Data, Neurons, Phosphorylation, Recombinant Proteins, Signal Transduction, Macrophage Colony-Stimulating Factor, Receptor, Macrophage Colony-Stimulating Factor, Prosencephalon, Amyloid beta-Protein Precursor, Cyclic AMP Response Element-Binding Protein, Neuroprotective Agents, Neurodegenerative Diseases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.